Singapore markets open in 6 hours 28 minutes

Lyell Immunopharma, Inc. (LYEL)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
1.9100+0.1800 (+10.40%)
At close: 04:00PM EST
1.9700 +0.06 (+3.14%)
After hours: 05:05PM EST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
48,503
84,683
10,650
7,756
657
Operating expenses
Research development
173,982
159,188
138,693
182,243
63,595
Selling general and administrative
80,164
117,307
89,057
46,881
39,151
Total operating expenses
250,787
271,741
225,426
219,693
102,746
Operating income or loss
-202,284
-187,058
-214,776
-211,937
-102,089
Total other income/expenses net
-7,637
-3,113
-36,608
1,526
-35,409
Income before tax
-190,099
-183,118
-250,219
-204,472
-129,377
Income from continuing operations
-190,099
-183,118
-250,219
-204,472
-129,377
Net income
-190,099
-183,118
-250,219
-204,472
-129,377
Net income available to common shareholders
-190,099
-183,118
-250,219
-208,054
-130,521
Basic EPS
-0.83
-0.74
-1.84
-0.98
-0.62
Diluted EPS
-0.83
-0.74
-1.84
-0.98
-0.62
Basic average shares
249,404
247,080
135,918
211,746
211,746
Diluted average shares
249,404
247,080
135,918
211,746
211,746